Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Journal of Viral Hepatitis
|
February 6, 2023
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis
Ira M Jacobson, Stefan Bourgeois, Phillipe Mathurin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 10, 2012
The performance of transient elastography compared to clinical acumen and routine tests - what is the incremental diagnostic value?
Grace E Dolman, Daan Nieboer, Ewout W Steyerberg, et al.
Hepatology (Baltimore, Md.)
|
August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
Sudeep Tanwar, Paul M Trembling, Indra N Guha, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 22, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
Alice Morgan, Sally Hartmanis, Emmanuel Tsochatzis, et al.
Frontline Gastroenterology
|
April 14, 2023
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)
Richard J Aspinall, Mark Hudson, Stephen D Ryder, et al.
Alimentary Pharmacology & Therapeutics
|
June 26, 2020
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study
Pietro Lampertico, Thomas Berg, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 28, 2023
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK
Victoria Hamill, Will Gelson, Douglas MacDonald, et al.
Journal of Hepatology
|
December 3, 2014
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
Kosh Agarwal, Scott K Fung, Tuan T Nguyen, et al.
Gastroenterology
|
January 4, 2017
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA
Nikhil Vergis, Stephen R Atkinson, Suzanne Knapp, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 14, 2019
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis
Christopher L Bowlus, Paul J Pockros, Andreas E Kremer, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Journal of Viral Hepatitis
|
February 6, 2023
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis
Ira M Jacobson, Stefan Bourgeois, Phillipe Mathurin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 10, 2012
The performance of transient elastography compared to clinical acumen and routine tests - what is the incremental diagnostic value?
Grace E Dolman, Daan Nieboer, Ewout W Steyerberg, et al.
Hepatology (Baltimore, Md.)
|
August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
Sudeep Tanwar, Paul M Trembling, Indra N Guha, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 22, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
Alice Morgan, Sally Hartmanis, Emmanuel Tsochatzis, et al.
Frontline Gastroenterology
|
April 14, 2023
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)
Richard J Aspinall, Mark Hudson, Stephen D Ryder, et al.
Alimentary Pharmacology & Therapeutics
|
June 26, 2020
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study
Pietro Lampertico, Thomas Berg, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 28, 2023
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK
Victoria Hamill, Will Gelson, Douglas MacDonald, et al.
Journal of Hepatology
|
December 3, 2014
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
Kosh Agarwal, Scott K Fung, Tuan T Nguyen, et al.
Gastroenterology
|
January 4, 2017
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA
Nikhil Vergis, Stephen R Atkinson, Suzanne Knapp, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 14, 2019
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis
Christopher L Bowlus, Paul J Pockros, Andreas E Kremer, et al.
Page
of 8